ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag national cancer institute cell molecular biology

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
3D Rendering of Molecular Interaction in CAR Chimeric Antigen Receptor
Next-generation CAR and TCR Cancer Therapies
Danielle Gerhard, PhD | Mar 15, 2024 | 10+ min read
From smart receptors to novel biologics, scientists plan to overcome the challenges of treating solid tumors.
Toppling the Genetic Dominoes in Bone Metastasis
Laura Tran, PhD | Feb 15, 2024 | 4 min read
A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies.
Molecular Biology
The Scientist Staff | Aug 30, 1992 | 1 min read
I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, C.C. Harris, "Mutational hotspot in the p53 gene in human hepatocellular carcinomas," Nature, 350:427-8, 1991. Curtis Harris (National Cancer Institute, Bethesda, Md.): "Classical epidemiology has successfully identified human populations at high cancer risk and associated the risk with exposure to environmental agents. For example, hepatitis B virus and aflatoxin B1 have been epidemiologically linked to human liver cancer. "More recen
Green and red fluorescent proteins in a zebrafish outline the animal’s vasculature in red and lymphatic system in green in a fluorescent image. Where the two overlap along the bottom of the animal is yellow.
Serendipity, Happenstance, and Luck: The Making of a Molecular Tool
Shelby Bradford, PhD | Dec 4, 2023 | 10+ min read
The common fluorescent marker GFP traveled a long road to take its popular place in molecular biology today.
Molecular Biology
The Scientist Staff | Jul 5, 1992 | 1 min read
N. Kato, M. Hijikata, Y. Ootsuyama, M. Nakagawa, et al., "Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis," Proceedings of the National Academy of Sciences, 87:9524-28, 1990. Nobuyuki Kato (National Cancer Center Research Institute, Tokyo): "Hepatitis C virus (HCV) is the major etiological agent of posttransfusional non-A, non-B hepatitis (NANBH) throughout the world. NANBH frequently develops into chronic hepatitis and cirrhosis and
National Medals for molecular biology
Jack Lucentini(jekluc@aol.com) | Oct 26, 2003 | 2 min read
Two US scientists receive highest presidential honor for groundbreaking work
Image showing monoclonal antibody treatment
The Resilience of Monoclonal Antibodies and their Makers
Laura Tran, PhD | Mar 15, 2024 | 10+ min read
The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.

Run a Search

ADVERTISEMENT